Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 20, 2000

View Archived Issues

Magainin presents new anticancer magainin peptide at H&Q

Esperion Therapeutics acquires novel peptides

Phoenix and CuraGen enter transgenic research agreement

QS-21 license granted to Elan

Ampakines increase neurotrophin expression in rats and mice

Immune Response receives USD 5 million payment from Agouron

North American Vaccine to seek NeisVac-C approval in U.K. shortly

Gliatech and Abgenix enter XenoMouse technology collaboration

Oxford BioMedica's LentiVector has potential application in cancer

SBIR grant awarded to Vion to advance preclinical development of TAPET vectors

Lipid-lowering compounds designed at HMR (Aventis)

Novel rotamase inhibitors with neurotrophic activity in development at BMS

Antiobesity agents from Novartis target the NPY Y5 receptor

Sepracor initiates large-scale study of (+)-zopiclone

Potassium channel inhibitors for arrhythmias emerge from ICAgen/Lilly collaboration

Searle designs double prodrugs of gpIIb/IIIa antagonists

Hyperforin acetate: stable hyperforin derivative with superior pharmacological activity

Beta-sheet breaker peptides: new hope for rare but devastating neurodegenerative diseases

Vasogen to begin clinical trial with VAS-991 for treatment of congestive heart failure

Xyrem reduces narcolepsy-associated cataplexy and EDS in the clinic

Clinical trial commences with Cell Therapeutics' novel paclitaxel

Joint venture formed by Ribozyme and Elan to develop anticancer ribozyme product

Myriad Genetics patent covers p19 therapeutic and diagnostic development

Novel, nonviral gene delivery method in development at Genteric; U.S. patent issued

CardioRex phase II trials scheduled to begin this quarter

Major European launch announced for Synagis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...